DCF Valuation Analysis
| Field |
Value |
| Company |
[Company Name] |
| Ticker |
[Ticker Symbol] |
| Analysis Date |
[Date] |
| Prepared By |
[Analyst Name] |
| Current Share Price |
$[X] |
| Shares Outstanding |
[X]M |
Executive Summary
[2-3 sentence overview of the valuation conclusion, including the implied value range per share compared to the current market price, and whether the stock appears undervalued, fairly valued, or overvalued.]
Valuation Summary
| Method |
Enterprise Value |
Equity Value |
Value Per Share |
vs Current Price |
| DCF (Perpetuity Growth) |
$[X]M |
$[X]M |
$[X] |
[X]% |
| DCF (Exit Multiple) |
$[X]M |
$[X]M |
$[X] |
[X]% |
| Comparable Companies |
$[X]M |
$[X]M |
$[X] |
[X]% |
| Blended Estimate |
$[X]M |
$[X]M |
$[X] |
[X]% |
Investment Thesis
[Summary of the investment case, including key strengths, risks, and catalysts.]
Historical Financial Summary
| ($M) |
FY-4 |
FY-3 |
FY-2 |
FY-1 |
LTM |
| Revenue |
[X] |
[X] |
[X] |
[X] |
[X] |
| Revenue Growth |
[X]% |
[X]% |
[X]% |
[X]% |
[X]% |
| Gross Profit |
[X] |
[X] |
[X] |
[X] |
[X] |
| Gross Margin |
[X]% |
[X]% |
[X]% |
[X]% |
[X]% |
| EBITDA |
[X] |
[X] |
[X] |
[X] |
[X] |
| EBITDA Margin |
[X]% |
[X]% |
[X]% |
[X]% |
[X]% |
| Net Income |
[X] |
[X] |
[X] |
[X] |
[X] |
| Free Cash Flow |
[X] |
[X] |
[X] |
[X] |
[X] |
WACC Calculation
Cost of Equity (CAPM)
| Component |
Value |
Source |
| Risk-Free Rate |
[X]% |
[10-Year Treasury] |
| Equity Risk Premium |
[X]% |
[Damodaran / internal] |
| Beta (Levered) |
[X] |
[Bloomberg / regression] |
| Size Premium |
[X]% |
[Duff & Phelps] |
| Company-Specific Risk |
[X]% |
[Analyst judgment] |
| Cost of Equity |
[X]% |
|
Cost of Debt
| Component |
Value |
| Pre-Tax Cost of Debt |
[X]% |
| Tax Rate |
[X]% |
| After-Tax Cost of Debt |
[X]% |
Capital Structure
| Component |
Market Value ($M) |
Weight |
| Equity |
[X] |
[X]% |
| Debt |
[X] |
[X]% |
| Total Capital |
[X] |
100% |
WACC Result: [X]%
Revenue Projections
| ($M) |
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
| Revenue |
[X] |
[X] |
[X] |
[X] |
[X] |
| Growth Rate |
[X]% |
[X]% |
[X]% |
[X]% |
[X]% |
Key Revenue Assumptions:
- [Assumption 1 with supporting rationale]
- [Assumption 2 with supporting rationale]
- [Assumption 3 with supporting rationale]
Free Cash Flow Projections
| ($M) |
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
| Revenue |
[X] |
[X] |
[X] |
[X] |
[X] |
| EBIT |
[X] |
[X] |
[X] |
[X] |
[X] |
| Taxes on EBIT |
([X]) |
([X]) |
([X]) |
([X]) |
([X]) |
| NOPAT |
[X] |
[X] |
[X] |
[X] |
[X] |
| D&A |
[X] |
[X] |
[X] |
[X] |
[X] |
| CapEx |
([X]) |
([X]) |
([X]) |
([X]) |
([X]) |
| Change in NWC |
([X]) |
([X]) |
([X]) |
([X]) |
([X]) |
| Unlevered FCF |
[X] |
[X] |
[X] |
[X] |
[X] |
| FCF Margin |
[X]% |
[X]% |
[X]% |
[X]% |
[X]% |
Terminal Value
Perpetuity Growth Method
| Component |
Value |
| Terminal FCF |
$[X]M |
| Terminal Growth Rate |
[X]% |
| WACC |
[X]% |
| Terminal Value |
$[X]M |
| TV as % of EV |
[X]% |
Exit Multiple Method
| Component |
Value |
| Terminal EBITDA |
$[X]M |
| Exit EV/EBITDA Multiple |
[X]x |
| Terminal Value |
$[X]M |
| TV as % of EV |
[X]% |
Enterprise Value Bridge
| Component |
Perpetuity Growth |
Exit Multiple |
| PV of Projected FCFs |
$[X]M |
$[X]M |
| PV of Terminal Value |
$[X]M |
$[X]M |
| Enterprise Value |
$[X]M |
$[X]M |
| Less: Net Debt |
($[X]M) |
($[X]M) |
| Less: Minority Interest |
($[X]M) |
($[X]M) |
| Equity Value |
$[X]M |
$[X]M |
| Diluted Shares (M) |
[X] |
[X] |
| Value Per Share |
$[X] |
$[X] |
Sensitivity Analysis
WACC vs Terminal Growth Rate (Enterprise Value, $M)
| WACC \ Growth |
[g-2]% |
[g-1]% |
[g]% |
[g+1]% |
[g+2]% |
| [WACC-2]% |
[X] |
[X] |
[X] |
[X] |
[X] |
| [WACC-1]% |
[X] |
[X] |
[X] |
[X] |
[X] |
| [WACC]% |
[X] |
[X] |
[X] |
[X] |
[X] |
| [WACC+1]% |
[X] |
[X] |
[X] |
[X] |
[X] |
| [WACC+2]% |
[X] |
[X] |
[X] |
[X] |
[X] |
Implied Share Price Range
| Scenario |
Share Price |
vs Current |
Upside/Downside |
| Bear Case (WACC+2%, g-2%) |
$[X] |
[X]% |
[X]% |
| Base Case |
$[X] |
[X]% |
[X]% |
| Bull Case (WACC-2%, g+2%) |
$[X] |
[X]% |
[X]% |
Key Risks to Valuation
- [Risk 1] - [Description and potential impact on value]
- [Risk 2] - [Description and potential impact on value]
- [Risk 3] - [Description and potential impact on value]
Comparable Company Analysis
| Company |
EV/Revenue |
EV/EBITDA |
P/E |
Growth |
Margin |
| [Comp 1] |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
| [Comp 2] |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
| [Comp 3] |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
| [Comp 4] |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
| Median |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
| [Target] |
[X]x |
[X]x |
[X]x |
[X]% |
[X]% |
Conclusion and Recommendation
Valuation Range: $[Low] - $[High] per share
Current Price: $[X]
Recommendation: [Buy / Hold / Sell]
[Final paragraph with investment recommendation rationale, key upside catalysts, and primary risks to monitor.]
Analysis generated using Financial Analyst Skill - DCF Valuation Model